4-BROMO-1-(TETRAHYDROFURAN-3-YL)-1H-PYRAZOLE, 95.0%, 250mg

(1S,2S)-1,2-Diphenylethane-1,2-diol, 95.0%, 1g

Analytical and precision scale Entris® II series Models with internal adjustment, not certified, 0.01 g, 1200 g, BCE1202i-1S

(4-Bromo-2-fluorophenyl)(piperidin-1-yl)methanone, 95.0%, 1g

Ethyl 2,2-dimethyl-1,3-dioxane-5-carboxylate, 95.0%, 25g

4-Methoxy-2-(trifluoromethyl)phenylboronic acid, 95.0%, 25g

1-(3-Methoxypropyl)-1h-pyrazol-3-amine, 95%, 1g

5-(Benzyloxy)-2-methylpyrimidine, 98%, 1g

L-glycero-alpha-D-manno-Heptopyranose 1,2,3,4,6,7-Hexaacetate>97.0%(GC)20mg

Diethyl 2,5-Dibromoterephthalate>98.0%(GC)25g

3-Cyano-N-(2,4-dimethoxybenzyl)-4-fluoro-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide, 97%, 1g

4-(4H-1,2,4-triazol-3-yl)phenol, 100mg

2-Bromo-5-methoxybenzoic acid, 98.0%, 500g